Business
CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show
CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show\r\n \r\n \r\n\r\n\r\nCBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show\r\n\r\n\r\n\r\n\r\n\r\n\"Inside the explosive rise of a wellness company outpacing a $200B+ global market\"\r\n Watch the full Morning Show interview → SCOTTSDALE, ARIZONA / ACCESS Newswire / December 2, 2025 / CBD Life Sciences Inc. (OTCID:CBDL) is gaining powerful investor momentum this week following a spotlight interview with CEO Lisa Nelson on The Morning Show. Nelson discussed CBDL's rapid expansion, new retail partnerships, rising demand for its flagship therapeutic products, and the company's long-term vision as it positions itself inside one of the fastest-growing wellness markets in the world. \r\n \r\n \r\n This high-visibility interview arrives during a period of acceleration for CBDL, as the company continues strengthening product distribution, manufacturing capabilities, and strategic alignments across multiple billion-dollar verticals - including therapeutic topicals, edibles, alkaline CBD functional water, veterinarian-developed animal wellness products, and advanced nutraceutical powders.\r\n A Market Quietly Evolving Into a $203 Billion Global Opportunity\r\n The CBD industry is experiencing a transformation few investors anticipated just a few years ago.\r\n Industry research shows:\r\n \r\n The global CBD market was valued at $14.6 billion in 2025, projected to rocket to $203.4 billion by 2034, representing an extraordinary 34%+ compound annual growth rate.\r\n CBD topicals, ingestibles, functional beverages, and pet wellness products are among the fastest-growing categories in health and consumer goods.\r\n Retail and e-commerce distribution continues expanding as CBD transitions from niche product to mainstream wellness staple.\r\n \r\n Against this backdrop, CBDL's aggressive multi-sector strategy places it in a uniquely favorable position to capture early-stage market share before full institutional saturation occurs.\r\n Lisa Nelson: \"Our mission isn't just to exist within this industry - it's to lead it through innovation, transparency, and results.\"\r\n During her interview, Nelson highlighted CBDL's expanding ecosystem of high-demand CBD wellness products and the company's commitment to premium, ...